We report here a case of risperidone-induced neuroleptic malignant syndrome in a 2.5-year-old boy who was given by mistake 2.5 mg risperidone instead of 0.25mg, as it is the youngest case reported in the literature.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Neuroleptic malignant syndrome is a rare, but potentially fatal idiosyncratic reaction to antipsychotic drugs that manifests itself consistently with hyperthermia, muscle rigidity, akinesia, altered mental state, autonomic instability, high creatine phosphokinase levels, and leukocytosis.
📊
Key Findings & Data:Neuroleptic malignant syndrome is a rare, but potentially fatal idiosyncratic reaction to antipsychotic drugs that manifests itself consistently with hyperthermia, muscle rigidity, akinesia, altered mental state, autonomic instability, high creatine phosphokinase levels, and leukocytosis.
💡
Conclusion & Impact:We report here a case of risperidone-induced neuroleptic malignant syndrome in a 2.5-year-old boy who was given by mistake 2.5 mg risperidone instead of 0.25mg, as it is the youngest case reported in the literature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Neuroleptic malignant syndrome is a rare, but potentially fatal idiosyncratic reaction to antipsychotic drugs that manifests itself consistently with hyperthermia, muscle rigidity, akinesia, altered mental state, autonomic instability, high creatine phosphokinase levels, and leukocytosis. We report here a case of risperidone-induced neuroleptic malignant syndrome in a 2.5-year-old boy who was given by mistake 2.5 mg risperidone instead of 0.25mg, as it is the youngest case reported in the literature.
Özet
Nöroleptik malign sendrom, nadir görülen ancak ölümcül olabilen, antipsikotik ilaçlara karşı gelişen idiosenkrazik bir reaksiyondur. Bu sendrom hipertermi, kas rijiditesi, akinezi, şuur değişikliği, otonomik disfonksiyon, yüksek kreatinin kinaz seviyesi, lökositoz ile karakterizedir. Bu yazıda, ris- peridona bağlı nöroleptik malign sendrom gelişen, 2,5 yaşındaki erkek olgu, literatürdeki en küçük olgu olması nedeniyle sunulmuştur.
🔖
Cite This Article
BAŞGÜL, Ş. S., SALTIK, S. (2022). Neuroleptic malignant syndrome due to risperidone overdose in a child: A case report. Klinik Psikofarmakoloji Bülteni, Cilt: 22 - Sayı: 1, 75–78. https://ajindex.com/articles/574105
Delay J, Deniker P. Drug induced extrapyramidal syndromes. In: Viniken PJ, Bruyn GW, eds. Handbook of Clinical Neurology: Diseases of the Basal Ganglia. Vol 6. Amsterdam: Elsevier; 1968. p. 248-66
Silva RR, Munoz DM, Alpert M, Perlmutter IR, Diaz J. Neuroleptic malignant syndrome in children and adolescents. J Am Acad Child Adolesc Psychiatry 1999; 38: 187-94
Gelder M, Gath D, Mayou et al. The Neuroleptic Malignant Syndrome. Oxford Texbook of Psychiatry, Third edition. M Gelder, D Gath, R Mayou et al (ed), Oxford University Press; 1996. p. 554-5
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition, Washington DC: American Psychiatric Association; 1994. p. 739-42
Unal F, Hizli S, Ozyurek H, Sonuvar B. Fever and altered consciousness are not always equal to central nervous system infection: neuroleptic malignant syndrome in a 15-year-old girl. Turk J Pediatr 1996;38(4): 505-10
Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry 1985;142(10):1137-45
Addonizio G, Susman VL, Roth SD. Neuroleptic malignant syndrome: a review and analysis of 115 cases. Biol Psychiatry 1987; 22:1004-20
Numa A. Neuroleptic malignant syndrome in children. Med J Aust 1991;155(6): 417-9
Hillis RE, Lee DA. Viral encephalitis complicated by neuroleptic malignant syndrome in a 7-year-old girl. Pediatr Emerg Care 2003; 19(2):99-100
Hanft A, Eggleston C, Bourgeois JA. Neuroleptic malignant syndrome in adolescent after brief exposure to olanzapine. J Child Adolesc Psychopharmacol 2005;14(3):481-7
Abu-Kishk I, Toledano M, Reis A, Daniel D, Berkovitch M. Neuroleptic malignant syndrome in a child treated with an atypical antipsychotic. J Toxicol Clin Toxicol 2004;42(6):921-5
Leibold J, Patel V, Hasan RA. Neuroleptic malignant syndrome associated with ziprasidone in an adolescent. Clin Ther 2004;26(7): 1105-8
Chungh DS, Kim BN, Cho SC. Neuroleptic malignanat syndrome due to three atypical antipsychotics in a child. J Psychopharmacol 2005;19(4):422-5
Memik NC, Karakaya I, Coskun A, Ağaoğlu B. Neuroleptic malignant syndrome in early adolescence: a case report. Turki